← All trials
NCT05465538
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 6, 2022
- Primary completion
- Jun 30, 2023
- Completion date
- Aug 30, 2023
- First posted
- Jul 19, 2022
- Last posted
- Aug 18, 2022
- Enrollment
- 24
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Yale UniversityLead sponsor
- National Institute on Drug Abuse (NIDA)Collaborator
- Yale UniversityOverall official - principal investigator
- Yale UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.